A longtime leader in healthcare improvement, we’re developing new ways to revolutionize the industry.
BioSpace | The U.S. Congress typically pins the high cost of healthcare on the pharmaceutical industry, citing sometimes exorbitant prices for disease-modifying therapies. But drug prices are...
While we’ve made some progress, unfortunately, it appears we still have work to do.
The Centers for Medicare & Medicaid Services (CMS) recently released the CY 2023 Outpatient Prospective Payment System (OPPS) and Ambulatory Surgical Center (ASC) Payment...
Premier responds to CMS' FY 2023 IPPS Rule.
The Centers for Medicare & Medicaid Services (CMS) recently released its calendar year (CY) 2023 proposed rules for the Physician Fee Schedule (PFS) and...
The Center for Medicare & Medicaid Innovation (CMMI) recently announced a new voluntary CMMI model focused on cancer care, the Enhancing Oncology Model (EOM)...
Premier urges Congress to substantially expand the number of physicians in the training pipeline.
Premier responds to CMS' proposed policies on the CY 2023 payment update, 340B, N95s and CDS.
FDA Public Workshop | Premier’s Soumi Saha was invited to participate in the workshop’s June 7 panel discussion: "Resilience Defined and Measured."
Premier calls for continued support of the enhanced marketplace premium tax credit.
Premier applauds CMS for addressing several aspects of the Medicare Shared Savings Program (MSSP).
MedTech Intelligence | Decentralized trials (DCTs) allow for a novel, agile and more cost-effective approach to an industry standard and traditional methodology.